Company profile

PolyPeptide Group AG insider transactions

POLYPE

Management transactions

10

Shareholding disclosures

83

First disclosure

04.05.2021

Last disclosure

30.05.2026

Company summary

Over 90 days: 0 purchases (CHF 0.00) and 12 sales (CHF 23 M). Disclosed flows are net selling.

Latest purchase
CHF 75’000

09.04.2025 · Non-executive member of the board of directors

Net flow 90 d
CHF -23’311’629

Buys − sales

Top shareholder
0%

Cryosphere Foundation

This page brings together all PolyPeptide Group AG (POLYPE) insider transactions: 10 management transactions and 83 significant shareholding disclosures published by SIX Exchange Regulation, from 04.05.2021 to 30.05.2026.

Detailed context

Six Exchange Regulation has published 10 management transactions and 83 significant shareholding disclosures regarding PolyPeptide Group AG, which can be monitored alongside other insider transactions. Over the last 90 days, there were 0 purchases and 12 sales totaling CHF 23'311'629, with the latest transaction recorded on 2026-10-30. The largest declared shareholders by voting rights include Foundation Mamont at 55.54%, Premier Miton European Opportunities Fund and Premier Portfolio Managers Limited both at 4.93%, and PRIMECAP Odyssey Aggressive Growth Fund at 3.2%.

Insider barometer

90 days

12 transactions

CHF -23’311’629

Net selling

Declared purchases 0%Declared sales 100%
Net flowNet selling

Declared purchases

CHF 0.00

Declared sales

CHF 23’311’629

Latest transaction

30.10.2026

Largest purchase

CHF 2’876’349

Largest sale

CHF 10’095’679

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Follow PolyPeptide Group AG’s disclosures

Find new disclosures in your watchlist. With Pro, receive email and Telegram alerts for your chosen companies.

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open

PolyPeptide Group AG insider transactions

SaleManagement transactions

PolyPeptide Group AG

Executive member of the board of directors / senior management · Other securities

CHF 6’321’929142’675 × CHF 44.3130.10.2026
SaleManagement transactions

PolyPeptide Group AG

Executive member of the board of directors / senior management · Other securities

CHF 296’3016’687 × CHF 44.3130.10.2026
SaleManagement transactions

PolyPeptide Group AG

Executive member of the board of directors / senior management · Other securities

CHF 156’7693’538 × CHF 44.3130.10.2026
SaleManagement transactions

PolyPeptide Group AG

Executive member of the board of directors / senior management · Registered shares

CHF 10’095’679227’842 × CHF 44.3130.10.2026
SaleManagement transactions

PolyPeptide Group AG

Non-executive member of the board of directors · Registered shares

CHF 190’0904’290 × CHF 44.3130.10.2026
SaleManagement transactions

PolyPeptide Group AG

Non-executive member of the board of directors · Registered shares

CHF 141’8193’193 × CHF 44.4230.10.2026
SaleManagement transactions

PolyPeptide Group AG

Non-executive member of the board of directors · Registered shares

CHF 1’316’09629’702 × CHF 44.3130.10.2026
SaleManagement transactions

PolyPeptide Group AG

Non-executive member of the board of directors · Registered shares

CHF 1’453’94432’813 × CHF 44.3130.10.2026
SaleManagement transactions

PolyPeptide Group AG

Non-executive member of the board of directors · Registered shares

CHF 2’008’08545’319 × CHF 44.3130.10.2026
SaleManagement transactions

PolyPeptide Group AG

Non-executive member of the board of directors · Registered shares

CHF 341’8287’760 × CHF 44.0520.10.2026

Latest shareholding disclosures